Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
1,131
Views
0
CrossRef citations to date
0
Altmetric
Original research

Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients

Sandra García-Muleroa Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, Barcelona, Spain;b Anatomy Unit, Department of Pathology and Experimental Therapy, and Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, SpainView further author information
,
Roberto Fornelinoa Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, Barcelona, SpainView further author information
,
Marco Puntac Bioinformatics Core, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UKView further author information
,
Stefano Lisec Bioinformatics Core, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UKView further author information
,
Mar Varelad Department of Pathology, Bellvitge University Hospital, Barcelona, SpainView further author information
,
Luis P. del Carpioe Procure Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, SpainView further author information
,
Rafael Morenoe Procure Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, SpainView further author information
,
Marcel Costa-Garcíae Procure Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, SpainView further author information
,
Dietmar Riederf Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, AustriaView further author information
,
Zlatko Trajanoskif Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, AustriaView further author information
,
Alena Grosg Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, SpainView further author information
,
Ramón Alemanye Procure Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, SpainView further author information
,
Josep María Piulatsh Department of Medical Oncology, ICO, IDIBELL and CIBERONC, Barcelona, SpainCorrespondence[email protected]
View further author information
&
Rebeca Sanz-Pamplonaa Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, Barcelona, Spain;i Institute for Health Research Aragon (IISA), ARAID Foundation, Aragon Government, University Hospital Lozano Blesa, Zaragoza, SpainCorrespondence[email protected]
View further author information
 show all
Article: 2261278 | Received 19 Apr 2023, Accepted 17 Sep 2023, Published online: 24 Oct 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.